Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters











Publication year range
1.
J Bone Miner Metab ; 41(6): 752-759, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37676507

ABSTRACT

INTRODUCTION: The discrepancy between bone mineral density (BMD), the gold standard for bone assessment, and bone strength is a constraint in diagnosing bone function and determining treatment strategies for several bone diseases. Gastric hypochlorhydria induced by clinically used proton pump inhibitor (PPI) therapy indicates a discordance between changes in BMD and bone strength. Here, we used Cckbr-deficient mice with gastric hypochlorhydria to examine the effect of gastric hypochlorhydria on bone mass, BMD, and preferential orientation of the apatite crystallites, which is a strong indicator of bone strength. MATERIALS AND METHODS: Cckbr-deficient mice were created, and their femurs were analyzed for BMD and preferential orientation of the apatite c-axis along the femoral long axis. RESULTS: Cckbr-deficient mouse femurs displayed a slight osteoporotic bone loss at 18 weeks of age; however, BMD was comparable to that of wild-type mice. In contrast, apatite orientation in the femur mid-shaft significantly decreased from 9 to 18 weeks. To the best of our knowledge, this is the first report demonstrating the deterioration of apatite orientation in the bones of Cckbr-deficient mice. CONCLUSION: Lesions in Cckbr-deficient mice occurred earlier in apatite orientation than in bone mass. Hence, bone apatite orientation may be a promising method for detecting hypochlorhydria-induced osteoporosis caused by PPI treatment and warrants urgent clinical applications.


Subject(s)
Achlorhydria , Receptor, Cholecystokinin B , Mice , Animals , Apatites , Bone and Bones , Bone Density , Femur/diagnostic imaging
2.
Biosci Biotechnol Biochem ; 86(3): 413-422, 2022 Feb 24.
Article in English | MEDLINE | ID: mdl-35025981

ABSTRACT

Aspergillus oryzae RIB40 has 11 aspartic endopeptidase genes. We searched for milk-clotting enzymes based on the homology of the deduced amino acid sequence with chymosins. As a result, we identified a milk-clotting enzyme in A. oryzae. We expected other Aspergillus species to have a homologous enzyme with milk-clotting activity, and we found the most homologous aspartic endopeptidase from A. luchuensis had milk-clotting activity. Surprisingly, 2 enzymes were considered as vacuole enzymes according to a study on A. niger proteases. The 2 enzymes from A. oryzae and A. luchuensis cleaved a peptide between the 105Phe-106Met bond in κ-casein, similar to chymosin. Although both enzymes showed proteolytic activity using casein as a substrate, the optimum pH values for milk-clotting and proteolytic activities were different. Furthermore, the substrate specificities were highly restricted. Therefore, we expected that the Japanese traditional fermentation agent, koji, could be used as an enzyme source for cheese production.


Subject(s)
Aspergillus oryzae
3.
Pathol Oncol Res ; 26(2): 1263-1268, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31256324

ABSTRACT

Milk fat globule-epidermal growth factor 8 (MFG-E8) is a glycoprotein secreted by the activated macrophages and acts as a bridge between apoptotic cells and phagocytes. Aside from macrophages, a variety of malignant cells also express MFG-E8. The objective of this study is to elucidate the clinical relevance and significance of MFG-E8 in the tumor microenvironment (TME) of patients with oral squamous cell carcinoma (OSCC). We investigated MFG-E8 expression in 74 patients with OSCC by immunohistochemistry and evaluated the relationship between MFG-E8 expression and various clinicopathological factors including immune cell infiltration. MFG-E8 expression was detected in 34 of 74 (45.9%) patients with OSCC and a significant correlation was observed with levels of infiltrating T cells, macrophages, and immunosuppressive M2 macrophages. Furthermore, MFG-E8 expression was also associated with clinical stage, lymphatic/vascular invasion, and Ki-67+ tumor cells but not with survival. Our results suggest that MFG-E8 may play an important role in shaping the immune suppressive network in TME as well as tumor progression.


Subject(s)
Antigens, Surface/biosynthesis , Head and Neck Neoplasms/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Milk Proteins/biosynthesis , Squamous Cell Carcinoma of Head and Neck/immunology , Tumor Microenvironment/immunology , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Female , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Squamous Cell Carcinoma of Head and Neck/pathology
4.
Anticancer Res ; 39(6): 3039-3046, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31177146

ABSTRACT

BACKGROUND/AIM: Programmed death-ligand 1 (PD-L1) expression in tumor cells is regulated by a close interrelation between tumor and stromal cells within the tumor microenvironment. Our aim was to evaluate the clinical and biological significance of PD-L1 expression in oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: PD-L1, cluster of differentiation (CD)4, CD8, and forkhead box P3 (FOXP3) expression in tumor tissues obtained from 77 patients with OSCC was evaluated by immunohistochemical staining, and then analyzed for associations with clinical and biological factors. RESULTS: Among the clinicopathological factors tested, only vascular invasion showed a trend toward lower PD-L1 expression (p=0.05). Metabolic tumor volume (MTV), and total lesion glycolysis (TLG) significantly positively correlated with PD-L1 expression (MTV, p=0.04; TLG, p=0.03). In patients with OSCC with high PD-L1 expression, those whose tumors had abundant infiltrating CD4+ T-cells showed a longer progression-free survival than those with low CD4+ T-cell infiltration (p=0.0452). CONCLUSION: As regulation of PD-L1 expression is complex, its evaluation combined with other markers may be useful to determine clinical applications of PD-L1 expression.


Subject(s)
B7-H1 Antigen/analysis , Biomarkers, Tumor/analysis , Mouth Neoplasms/immunology , Squamous Cell Carcinoma of Head and Neck/immunology , Tumor Microenvironment , Adult , Aged , Aged, 80 and over , CD4-Positive T-Lymphocytes/immunology , Female , Glycolysis , Humans , Immunohistochemistry , Lymphocytes, Tumor-Infiltrating/immunology , Male , Middle Aged , Mouth Neoplasms/diagnostic imaging , Mouth Neoplasms/metabolism , Mouth Neoplasms/surgery , Positron-Emission Tomography , Progression-Free Survival , Squamous Cell Carcinoma of Head and Neck/diagnostic imaging , Squamous Cell Carcinoma of Head and Neck/metabolism , Squamous Cell Carcinoma of Head and Neck/surgery , Time Factors , Tumor Burden
5.
Neurosci Lett ; 698: 69-75, 2019 04 17.
Article in English | MEDLINE | ID: mdl-30593874

ABSTRACT

In the current study, we aimed to analyze the lipid changes in the dorsal root ganglion (DRG) after sciatic nerve transection (SNT) using matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS). We found that the arachidonic acid-containing phosphatidylcholine (AA-PC), PC(16:0/20:4) largely increased, while PC(16:0/18:1), PC(18:0/18:1) and phosphatidic acid (PA)(36:2) levels largely decreased in the DRG following nerve injury. Previous studies show that the increase in PC(16:0/20:4) was associated with neuropathic pain and that decrease in PC(16:0/18:1), PC(18:0/18:1), and PA(36:2) were due to producing lysophosphatidic acid (LPA), an initiator for neuropathic pain. These results suggest that the lipid changes in DRG after SNT could be the result of changes for the cause of neuropathic pain. Thus, blocking of LPA could be potential for treatment of neuropathic pain.


Subject(s)
Arachidonic Acid/metabolism , Ganglia, Spinal/metabolism , Lysophospholipids/metabolism , Phosphatidylcholines/metabolism , Animals , Mice, Inbred C57BL , Neuralgia/metabolism , Phosphatidic Acids/metabolism , Sciatic Nerve/injuries , Sciatic Nerve/metabolism
6.
J Craniofac Surg ; 28(3): 771-774, 2017 May.
Article in English | MEDLINE | ID: mdl-28468163

ABSTRACT

BACKGROUND: Indications for laser therapy for slow-flow vascular malformations in the oral and maxillofacial regions have not been clearly documented. The authors aimed to estimate the frequency of resolution of slow-flow vascular malformations and to identify risk and prognostic factors associated with resolution in potassium titanyl phosphate (KTP) laser treatment. METHODS: This study was designed as a prospective cohort study. Patients who had diagnosed slow-flow vascular malformations were continuously assigned to receive KTP laser therapy. All patients had intralesional laser photocoagulation performed under local anesthesia. Administered power of the KTP laser was fixed at 2 watts throughout the procedure in all patients. The primary endpoint was to understand the frequency of resolution of slow-flow vascular malformations in KTP laser treatment. Secondary endpoints were: treatment outcomes based on lesion size; treatment outcomes based on location; treatment outcomes based on total energy in joules; types of complications. Treatment outcomes were judged by a clinical assessment as well as reduction in lesion size on magnetic resonance imaging. RESULTS: Data were obtained from 26 patients (9 men, 17 women) with 38 lesions. The average lesion size was 13.5 ±â€Š7.7 mm. Treatment outcomes based on lesion size showed that cure and regression were obtained in lesions less than 30 mm in size. However, lesions larger than 30 mm showed no response. Lesions in the tongue and lips showed higher cure rates than in other areas. Treatment outcomes based on administered total energy in joules showed that 68% of lesions were treated and responded well at less than 400 joules. Complication rate was relatively high in the buccal mucosal lesions. Immediate postoperative complications such as necrosis were more common in high-energy administration than in low-energy administration. CONCLUSION: Our results indicated that KTP laser therapy was effective for slow-flow vascular malformations less than 30 mm in size without significant side effects.


Subject(s)
Blood Flow Velocity/physiology , Laser Therapy/methods , Lasers, Solid-State/therapeutic use , Mouth/blood supply , Phosphates , Surgery, Oral/methods , Titanium , Vascular Malformations/surgery , Female , Follow-Up Studies , Hemodynamics , Humans , Low-Level Light Therapy/methods , Magnetic Resonance Imaging , Male , Middle Aged , Prospective Studies , Treatment Outcome , Ultrasonography, Doppler, Color , Vascular Malformations/diagnosis , Vascular Malformations/physiopathology
7.
PLoS One ; 12(5): e0177595, 2017.
Article in English | MEDLINE | ID: mdl-28542572

ABSTRACT

Peripheral nerve injury induces substantial molecular changes in the somatosensory system that leads to maladaptive plasticity and cause neuropathic pain. Understanding the molecular pathways responsible for the development of neuropathic pain is essential to the development of novel rationally designed therapeutics. Although lipids make up to half of the dry weight of the spinal cord, their relation with the development of neuropathic pain is poorly understood. We aimed to elucidate the regulation of spinal lipids in response to neuropathic peripheral nerve injury in mice by utilizing matrix-assisted laser desorption/ionization imaging mass spectrometry, which allows visualization of lipid distribution within the cord. We found that arachidonic acid (AA) containing [PC(diacyl-16:0/20:4)+K]+ was increased temporarily at superficial ipsilateral dorsal horn seven days after spared nerve injury (SNI). The spatiotemporal changes in lipid concentration resembled microglia activation as defined by ionized calcium binding adaptor molecule 1 (Iba1) immunohistochemistry. Suppression of microglial function through minocycline administration resulted in attenuation of hypersensitivity and reduces [PC(diacyl-16:0/20:4)+K]+ elevation in the spinal dorsal horn. These data suggested that AA containing [PC(diacyl-16:0/20:4)+K]+ is related to hypersensitivity evoked by SNI and implicate microglial cell activation in this lipid production.


Subject(s)
Arachidonic Acid/metabolism , Microglia/metabolism , Phosphatidylcholines/metabolism , Sciatic Nerve/injuries , Spinal Cord Dorsal Horn/metabolism , Animals , Calcium-Binding Proteins/metabolism , Lipid Metabolism/drug effects , Male , Mice , Mice, Inbred C57BL , Microfilament Proteins/metabolism , Microglia/drug effects , Minocycline/pharmacology , Neuralgia/etiology , Neuralgia/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Spinal Cord Dorsal Horn/drug effects
8.
Sci Rep ; 6: 26427, 2016 05 23.
Article in English | MEDLINE | ID: mdl-27210057

ABSTRACT

Peripheral nerve injury (PNI) triggers cellular and molecular changes in the spinal cord. However, little is known about how the polyunsaturated fatty acid-containing phosphatidylcholines (PUFA-PCs) are regulated in the spinal cord after PNI and the association of PUFA-PCs with the non-neuronal cells within in the central nervous system (CNS). In this study, we found that arachidonic acid-containing phosphatidylcholine (AA-PC), [PC(16:0/20:4)+K](+), was significantly increased in the ipsilateral ventral and dorsal horns of the spinal cord after sciatic nerve transection, and the increased expression of [PC(16:0/20:4)+K](+) spatiotemporally resembled the increase of reactive microglia and the astrocytes. From the lipidomics point of view, we conclude that [PC(16:0/20:4)+K](+) could be the main phospholipid in the spinal cord influenced by PNI, and the regulation of specific phospholipid molecule in the CNS after PNI is associated with the reactive microglia and astrocytes.


Subject(s)
Arachidonic Acid/metabolism , Astrocytes/metabolism , Microglia/metabolism , Peripheral Nerve Injuries/metabolism , Phosphatidylcholines/metabolism , Animals , Disease Models, Animal , Female , Lipid Metabolism , Mice , Peripheral Nerve Injuries/etiology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Spinal Cord/cytology , Spinal Cord/metabolism
9.
Cornea ; 35(4): 569-71, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26863498

ABSTRACT

PURPOSE: To report an adult case of mumps keratitis with mumps virus in aqueous humor and decreased corneal endothelial cell density. METHODS: Case report. RESULTS: A 60-year-old female with a 39°C fever and bilateral parotid swelling diagnosed with mumps and treated for photophobia, pain, redness, and decreased vision in 1 eye, was referred to our hospital when her condition deteriorated despite receiving betamethasone phosphate instillation and antiglaucoma agents for elevated intraocular pressure (52 mm Hg) and iritis. Her right eye was normal, whereas her left eye showed 20/400 visual acuity, 21 mm Hg intraocular pressure, ciliary injection and edema, opacity, and Descemet folds in the entire cornea. Round white keratic precipitates were present on the posterior corneal surface, whereas anterior chamber cells could not be examined in detail because of corneal edema. Mumps virus was detected by reverse transcriptase polymerase chain reaction in an aqueous humor sample taken at the time of admission. Following diagnosis of keratitis, administration of 30 mg oral prednisolone daily and frequent instillation of betamethasone phosphate steadily improved her corneal edema and opacity. In her left eye, visual acuity recovered to 20/16 and keratitis was resolved at 4 weeks; however, corneal endothelial cell density was significantly decreased to less than 400 per square millimeter. CONCLUSIONS: Mumps keratitis may cause severe corneal endothelial cell loss.


Subject(s)
Aqueous Humor/virology , Corneal Ulcer/virology , Eye Infections, Viral/virology , Mumps virus/isolation & purification , Mumps/virology , RNA, Viral/genetics , Administration, Oral , Administration, Topical , Betamethasone/therapeutic use , Corneal Ulcer/diagnosis , Corneal Ulcer/drug therapy , Eye Infections, Viral/diagnosis , Eye Infections, Viral/drug therapy , Female , Glucocorticoids/therapeutic use , Humans , Middle Aged , Mumps/diagnosis , Mumps/drug therapy , Mumps virus/genetics , Parotid Diseases/virology , Prednisolone/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction
10.
Appl Microbiol Biotechnol ; 100(11): 4947-58, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26846741

ABSTRACT

Three extracellular dipeptidyl peptidase genes, dppB, dppE, and dppF, were unveiled by sequence analysis of the Aspergillus oryzae genome. We investigated their differential enzymatic profiles, in order to gain an understanding of the diversity of these genes. The three dipeptidyl peptidases were expressed using Aspergillus nidulans as the host. Each recombinant enzyme was purified and subsequently characterized. The enzymes displayed similar optimum pH values, but optimum temperatures, pH stabilities, and substrate specificities varied. DppB was identified as a Xaa-Prolyl dipeptidyl peptidase, while DppE scissile substrates were similar to the substrates for Aspergillus fumigatus DPPV (AfDPPV). DppF was found to be a novel enzyme that could digest both substrates for A. fumigatus DPPIV and AfDPPV. Semi-quantitative PCR revealed that the transcription of dppB in A. oryzae was induced by protein substrates and repressed by the addition of an inorganic nitrogen source, despite the presence of protein substrates. The transcription of dppE depended on its growth time, while the transcription of dppF was not affected by the type of the nitrogen source in the medium, and it started during the early stage of the fungal growth. Based on these results, we conclude that these enzymes may represent the nutrition acquisition enzymes. Additionally, DppF may be one of the sensor peptidases responsible for the detection of the protein substrates in A. oryzae environment. DppB may be involved in nitrogen assimilation control, since the transcription of dppB was repressed by NaNO3, despite the presence of protein substrates.


Subject(s)
Aspergillus oryzae/enzymology , Aspergillus oryzae/genetics , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/chemistry , Aspergillus fumigatus/enzymology , Aspergillus fumigatus/genetics , Aspergillus nidulans/enzymology , Aspergillus nidulans/genetics , DNA, Fungal/isolation & purification , Hydrogen-Ion Concentration , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Substrate Specificity
11.
Odontology ; 104(3): 363-71, 2016 Sep.
Article in English | MEDLINE | ID: mdl-25956267

ABSTRACT

It remains unclear whether dental implants are a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ). We retrospectively evaluated the status of dental implants in patients given intravenous bisphosphonates (BPs) in a breast cancer cohort to elucidate the risk for BRONJ at the implant site. We established a BRONJ oral monitoring program for 247 breast cancer patients given intravenous BP in our institution. The 3-year cumulative incidence rate was determined. The systemic and local risk factors of 44 patients who completed comprehensive oral examinations were evaluated by logistic regression analysis. The 3-year cumulative incidence rate of the 247 patients was 0.074 % (8/247, 95 % CI 0.0081-0.014). In the 44 orally examined patients, 6 (13.6 %: 6/44) had dental implants. Of these 6 patients, 1 developed BRONJ at the implant site. There were no significant differences in the age, total BP treatment period, number of residual teeth, time of regular oral monitoring, oral hygiene level, or dental implant insertion. Although a case of ONJ was identified, dental implants which were inserted before intravenous BP administration were not a risk factor for the development of ONJ in breast cancer patients.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Bone Density Conservation Agents/adverse effects , Breast Neoplasms/drug therapy , Denosumab/adverse effects , Dental Implants/adverse effects , Adult , Aged , Aged, 80 and over , Female , Humans , Japan , Middle Aged , Retrospective Studies , Risk Factors
12.
Biosci Biotechnol Biochem ; 78(8): 1328-36, 2014.
Article in English | MEDLINE | ID: mdl-25130734

ABSTRACT

Alternative splicing is thought to be a means for diversification of products by mRNA modification. Although some intron retentions are predicted by transcriptome analysis in Aspergillus oryzae, its physiological significance remains unknown. We found that intron retention occurred occasionally in the serine-type carboxypeptidase gene, ocpG. Analysis under various culture conditions revealed that extracellular nitrogen conditions influence splicing patterns; this suggested that there might be a correlation between splicing efficiency and the necessity of OcpG activity for obtaining a nitrogen source. Since further analysis showed that splicing occurred independently in each intron, we constructed ocpG intron-exchanging strain by interchanging the positions of intron-1 and intron-2. The splicing pattern indicated the probability that ocpG intron retention was affected by the secondary structures of intronic mRNA.


Subject(s)
Alternative Splicing , Aspergillus oryzae/enzymology , Aspergillus oryzae/genetics , Carboxypeptidases/genetics , Gene Expression Regulation, Fungal/genetics , Introns/genetics , Aspergillus oryzae/metabolism , Base Sequence , Nitrogen/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism
14.
Appl Environ Microbiol ; 78(22): 8154-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22961905

ABSTRACT

Aspergillus oryzae has an ortholog of Saccharomyces cerevisiae KEX1, termed kexA. A truncated form of KexA protein showed serine-type carboxypeptidase activity and somewhat broader substrate specificity than Kex1 protease. Furthermore, our results indicated that KexA is required for normal growth of A. oryzae and that it might be involved in hyphal branching.


Subject(s)
Aspergillus oryzae/enzymology , Carboxypeptidases/metabolism , Hyphae/enzymology , Virulence Factors/metabolism , Aspergillus oryzae/growth & development , Carboxypeptidases/chemistry , Hyphae/growth & development , Saccharomyces cerevisiae/enzymology , Substrate Specificity , Virulence Factors/chemistry
15.
Biosci Biotechnol Biochem ; 75(4): 662-8, 2011.
Article in English | MEDLINE | ID: mdl-21512241

ABSTRACT

Gene AO090103000153 is unique to Aspergillus oryzae RIB40 and A. flavus NRRL3357, and is speculated to encode a serine-type carboxypeptidase. In this study, we purified and characterized a heterologously expressed gene product of AO090103000153. 5'-Rapid amplification of cDNA ends indicated that the translation start site of the gene is located 1,586 bp downstream of the translation start site predicted by the genome sequencing project. The gene, starting from the revised translation start codon, termed ocpC, was transcribed constantly in A. oryzae RIB40. Purified recombinant OcpC exhibited the enzymatic properties of a serine-type carboxypeptidase. This protease was stable at temperatures below 45°C and a low pH, and had broad substrate specificity for N-acylpeptides, but it exhibited significantly lower specific activity and a lower k(cat) value for substrates than previously reported serine-type carboxypeptidases from A. oryzae.


Subject(s)
Aspergillus oryzae/enzymology , Carboxypeptidases/metabolism , Recombinant Proteins/metabolism , Amino Acid Sequence , Aspergillus nidulans/genetics , Aspergillus oryzae/genetics , Carboxypeptidases/chemistry , Carboxypeptidases/genetics , Carboxypeptidases/isolation & purification , Genetic Vectors/genetics , Molecular Sequence Data , Protein Biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Species Specificity , Transcription, Genetic
16.
Biosci Biotechnol Biochem ; 74(5): 1000-6, 2010.
Article in English | MEDLINE | ID: mdl-20460731

ABSTRACT

Carboxypeptidase O from Aspergillus oryzae IAM2640 is a serine-type carboxypeptidase. In this study, we cloned and sequenced cDNA and genomic DNA carrying ocpO encoding carboxypeptidase O. The results showed that the length of ocpO was 1,816 bp, and the open reading frame encoded a putative preproenzyme composed of 472 amino acid residues of the mature carboxypeptidase O and an additional N-terminal sequence of 50 amino acid residues. A BLASTN search revealed that a gene, AO090020000351, in A. oryzae RIB40, which is strain used in genome-wide sequencing, is a homolog of ocpO. The difference between AO090020000351 and ocpO was only one nucleotide. The difference caused substitution of Ala for Pro at the 277th position of the enzyme; therefore the protein encoded by AO090020000351 was overproduced and purified. The purified protein showed enzymatic properties similar to carboxypeptidase O, indicating that carboxypeptidase O and protease encoded by AO090020000351 are same enzyme.


Subject(s)
Aspergillus oryzae/genetics , Carboxypeptidases/genetics , Amino Acid Sequence , Aspergillus oryzae/enzymology , Base Sequence , Carboxypeptidases/chemistry , Carboxypeptidases/isolation & purification , Carboxypeptidases/metabolism , Cloning, Molecular , DNA, Complementary/genetics , DNA, Fungal/genetics , Databases, Genetic , Enzyme Stability , Genome, Fungal/genetics , Hydrogen-Ion Concentration , Molecular Sequence Data , Protease Inhibitors/pharmacology , Sequence Alignment , Sequence Homology, Nucleic Acid , Substrate Specificity
17.
Appl Microbiol Biotechnol ; 85(2): 335-46, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19557408

ABSTRACT

In the genome of Aspergillus oryzae, 12 genes have been predicted to encode serine-type carboxypeptidases. However, the carboxypeptidase activities of the proteins encoded by these genes have not yet been confirmed experimentally. In this study, we have constructed three of these 12 genes overexpressing strains using Aspergillus nidulans and characterized their overproduced recombinant proteins. Of these three genes, one was previously named cpI; the other two have not been reported yet, and hence, we named them ocpA and ocpB. The recombinant proteins released amino acid residues from the C terminus of peptides, and the activity of the enzymes was inhibited by phenylmethylsulfonyl fluoride, indicating the enzymes to be serine-type carboxypeptidases. Recombinant OcpA, OcpB, and CpI were stable at 45 degrees C, 55 degrees C, and 55 degrees C, respectively, at a low pH. The enzymatic properties of recombinant OcpB were different from those of any reported serine-type carboxypeptidase. On the other hand, recombinant OcpA had similar enzymatic properties to A. oryzae carboxypeptidases O1 and O2. The DNA and N-terminal amino acid sequences of carboxypeptidases O1 and O2 from A. oryzae IAM2640 were similar to those of OcpA. Result of transcriptional analysis of ocpA, ocpB, and cpI suggest differences in transcriptional regulation between these genes.


Subject(s)
Aspergillus oryzae/enzymology , Carboxypeptidases/genetics , Amino Acid Sequence , Aspergillus oryzae/genetics , Base Sequence , Carboxypeptidases/chemistry , Carboxypeptidases/drug effects , Carboxypeptidases/metabolism , DNA Primers , Enzyme Inhibitors/pharmacology , Enzyme Stability , Genetic Vectors , Genome-Wide Association Study , Kinetics , Molecular Sequence Data , Phenylmethylsulfonyl Fluoride/pharmacology , Plasmids , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Homology, Amino Acid
18.
Exp Hematol ; 32(1): 95-103, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14725906

ABSTRACT

OBJECTIVE: We generated cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CTL) in vitro using dendritic cells (DC) pulsed with crude CMV antigens (Ag). PATIENTS AND METHODS: Mononuclear cells from healthy CMV-seropositive or seronegative volunteers and from stem cell transplant (SCT) recipients were cultured with CD14(+) monocyte-derived DC prepulsed with CMV Ag and then matured in vitro with lipopolysaccharide and tumor necrosis factor-alpha. After proliferation, cells were checked for phenotype (CD4/CD8), while killing activity was measured by 51Cr-release assay. RESULTS: CD4(+) T cells, the main proliferating cells from both seropositive and seronegative individuals, killed autologous Ag-pulsed DC but not vehicle-pulsed autologous DC or CMV-pulsed allogeneic DC. Similar CTL induction was accomplished from SCT recipients. Significant killing of autologous CMV-infected fibroblasts required 16-hour incubation as opposed to the standard 4-hour incubation, which was prevented by either a perforin inhibitor or anti-Fas ligand monoclonal antibody. CTL enhanced surface HLA-DR expression of CMV-infected fibroblasts, and their activity was neutralized by anti-HLA-DR monoclonal antibody. CONCLUSION: CMV-specific CD4(+) CTL were inducible with or without antiviral humoral immunity, even from immunosuppressed SCT recipients. These CTL showed perforin- and Fas/Fas ligand-mediated cytotoxicity after long-term (16-hour) contact with CMV-infected targets.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Hematopoietic Stem Cell Transplantation , T-Lymphocytes, Cytotoxic/immunology , Antigens, Viral/immunology , Cytotoxicity, Immunologic , Dendritic Cells/physiology , HLA-DR Antigens/analysis , Humans
19.
Hum Immunol ; 64(12): 1144-51, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14630396

ABSTRACT

CD11c(+) peripheral blood myeloid dendritic cells (MDC), and CD123(bright) plasmacytoid cells (PDC), are two human dendritic cell (DC) populations. In the present study, the percentages of MDC [lin(-)/HLA-DR(+)/CD123(-)/CD11c(+)] and PDC [lin(-)/HLA-DR(+)/CD123(bright)] in a peripheral blood (PB) sample obtained from women at the time of delivery and in their umbilical cord blood (UCB) were compared with those in the PB of healthy volunteers. The percentages of MDC and PDC were determined by four-color flow cytometry. The percentages of MDC and PDC were significantly lower in the PB obtained at delivery (MDC, 0.11% +/- 0.08%; PDC, 0.06% +/- 0.06%) and in the UCB (MDC, 0.15% +/- 0.03%; PDC, 0.05% +/- 0.05%) than in the PB of the controls (males, 0.28% +/- 0.12%, 0.11% +/- 0.06%; females, 0.32% +/- 0.13%, 0.11% +/- 0.07%). Among the pregnant women at delivery, there were significant correlations between the percentage of MDC or percentage of PDC in the PB at delivery and the respective parameter in the UCB. The PB of other pregnant women, at 20-35 weeks of gestational age, also indicated significantly low percentages of MDC and PDC (0.1% +/- 0.1%, 0.06% +/- 0.07%). The ratio of MDC/PDC was not reduced in the UCB (4.25 +/- 2.74), but was reduced in the PB obtained at delivery and the PB obtained during pregnancy (0.79 +/- 0.91) in comparison with that in age-matched, nonpregnant females (3.96 +/- 2.95). It was assumed that reduction of MDC during pregnancy plays an important role in maintaining immune tolerance against the embryo.


Subject(s)
CD11c Antigen/immunology , Dendritic Cells/immunology , Fetal Blood/cytology , Myeloid Cells/immunology , Receptors, Interleukin-4/immunology , Adult , Blood Cell Count , Dendritic Cells/cytology , Female , Flow Cytometry , Humans , Male , Myeloid Cells/cytology , Pregnancy
20.
Cancer Immunol Immunother ; 52(10): 625-31, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12802518

ABSTRACT

PURPOSE: The first objective of this study was to investigate in vitro effects of alpha-galactosylceramide (alphaGalCer) on the proliferation of umbilical cord blood (UCB) natural killer T (NKT) cells and enhancement of their cytotoxicity. The second one is to examine whether purified NKT cells could affect the cytotoxicity of UCB-NK cells either in the presence or absence of dendritic cells (DCs). METHODS: Mononuclear cells (MNCs) from UCB were cultured for 2 weeks in the presence of IL-2 (100 U/ml), with or without alphaGalCer. The effect of neutralizing monoclonal antibodies (MoAb) against TCRValpha24 and CD1d was also examined. TCRValpha24 Vbeta11 double positive NKT cells were purified by FACS sorter and then cocultured with syngeneic isolated UCB(-)CD56(+)NK cells in either the presence or absence of DCs. The cytotoxicity against various malignant cell targets and cytokine production was determined. RESULTS: The addition of alphaGalCer induced human NKT cells to proliferate in UCB-MNCs to a greater extent than in adult PB-MNCs. However, it suppressed the cytotoxic activity against malignant cell targets. Anti-TCRValpha24 and CD1d MoAb recovered the cytotoxicity by inhibiting the proliferation of UCB-NKT cells. NKT cells cocultured with auto-DCs significantly increased NK cell cytotoxicity against K562, and Raji cells and produced IFN-gamma at much higher levels than UCB-NKT cells alone. CONCLUSION: In UCB samples, alphaGalCer-pulsed DCs and NKT cells acted together to enhance NK cytotoxicity in vitro.


Subject(s)
Cytotoxicity, Immunologic , Galactosylceramides/pharmacology , Killer Cells, Natural/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology , T-Lymphocytes/immunology , Adult , Antibodies, Monoclonal , Antigens, CD1/analysis , Antigens, CD1/immunology , Antigens, CD1d , Antigens, Neoplasm/analysis , Antigens, Neoplasm/immunology , Cell Division , Coculture Techniques , Dendritic Cells/immunology , Enzyme-Linked Immunosorbent Assay , Fetal Blood , Flow Cytometry , Humans , Interleukins/pharmacology , K562 Cells , Lymphocyte Activation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL